Clinical Trial Update: Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections [Phase 2]

View source ↗

Summary

A Phase 2 study is planned to evaluate oral voriconazole for resistant dermatophyte infections, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatophytosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Sheikh Zayed Medical College | Conditions: Dermatophyte Infection | Phase 2 | Status: NOT_YET_RECRUITING